Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.1318 | 0.1318 |
Mycobacterium ulcerans | cytochrome P450 188A3 Cyp188A3 | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium tuberculosis | Probable cytochrome P450 140 Cyp140 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium ulcerans | cytochrome P450 189A7 Cyp189A7 | 0.0048 | 0.2068 | 0.2033 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0018 | 0.0044 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 130 Cyp130 | 0.0048 | 0.2068 | 0.2717 |
Echinococcus multilocularis | 0.0048 | 0.2068 | 0.9119 | |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.2453 | 0.2453 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0128 | 0.7495 | 1 |
Echinococcus granulosus | cytochrome P450 2K1 | 0.0048 | 0.2068 | 0.9119 |
Mycobacterium ulcerans | cytochrome P450 143A4 Cyp143A4 | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | 0.0048 | 0.2068 | 0.2717 |
Toxoplasma gondii | thioredoxin reductase | 0.0051 | 0.2268 | 1 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0018 | 0.0044 | 0.5 |
Mycobacterium tuberculosis | Possible cytochrome P450 135A1 Cyp135A1 | 0.0048 | 0.2068 | 0.2717 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0048 | 0.2068 | 0.2068 |
Mycobacterium tuberculosis | Probable cytochrome P450 125 Cyp125 | 0.0048 | 0.2068 | 0.2717 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0166 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0118 | 0.6796 | 0.6796 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0051 | 0.2268 | 0.2268 |
Mycobacterium tuberculosis | Probable cytochrome P450 132 Cyp132 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium ulcerans | cytochrome P450 140A5 Cyp140A5 | 0.0048 | 0.2068 | 0.2033 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0051 | 0.2268 | 0.2234 |
Mycobacterium tuberculosis | Probable cytochrome P450 143 Cyp143 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium tuberculosis | Probable cytochrome P450 144 Cyp144 | 0.0048 | 0.2068 | 0.2717 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0051 | 0.2268 | 1 |
Leishmania major | cytochrome p450-like protein | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium tuberculosis | Probable cytochrome P450 137 Cyp137 | 0.0048 | 0.2068 | 0.2717 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.2453 | 0.2453 |
Trypanosoma brucei | trypanothione reductase | 0.0051 | 0.2268 | 0.2234 |
Mycobacterium tuberculosis | Cytochrome P450 51 Cyp51 (CYPL1) (P450-L1A1) (sterol 14-alpha demethylase) (lanosterol 14-alpha demethylase) (P450-14DM) | 0.0048 | 0.2068 | 0.2717 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0048 | 0.2068 | 0.2033 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0018 | 0.0044 | 0.0044 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0166 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0166 | 1 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0116 | 0.6629 | 0.8837 |
Trypanosoma brucei | Lanosterol 14-alpha demethylase | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium ulcerans | cytochrome P450 191A3 Cyp191A3 | 0.0048 | 0.2068 | 0.2033 |
Leishmania major | lanosterol 14-alpha-demethylase, putative | 0.0048 | 0.2068 | 0.2033 |
Leishmania major | cytochrome p450-like protein | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium ulcerans | cytochrome P450 108B4 Cyp108B4 | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium tuberculosis | Cytochrome P450 121 Cyp121 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0116 | 0.6629 | 0.8837 |
Mycobacterium ulcerans | cytochrome P450 187A5 Cyp187A5 | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0128 | 0.7495 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 139 Cyp139 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium tuberculosis | Probable cytochrome P450 141 Cyp141 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium tuberculosis | Possible cytochrome P450 126 Cyp126 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium ulcerans | cytochrome P450 143A3 Cyp143A3 | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium ulcerans | cytochrome P450 126A3 Cyp126A3 | 0.0048 | 0.2068 | 0.2033 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0051 | 0.2268 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1318 | 0.1318 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0128 | 0.7495 | 1 |
Loa Loa (eye worm) | cytochrome P450 | 0.0048 | 0.2068 | 0.2068 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0051 | 0.2268 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0048 | 0.2068 | 0.2068 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0116 | 0.6629 | 0.8837 |
Brugia malayi | glutathione reductase | 0.0051 | 0.2268 | 0.2268 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.2453 | 0.2453 |
Brugia malayi | Thioredoxin reductase | 0.0051 | 0.2268 | 0.2268 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0128 | 0.7495 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0018 | 0.0044 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 124A1, Cyp124A1 | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium tuberculosis | Possible cytochrome P450 135B1 Cyp135B1 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium tuberculosis | Probable cytochrome P450 138 Cyp138 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium ulcerans | cytochrome P450 123A3 Cyp123A3 | 0.0048 | 0.2068 | 0.2033 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0018 | 0.0044 | 0.0194 |
Mycobacterium ulcerans | cytochrome P450 142A3 Cyp142A3 | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0116 | 0.6629 | 0.8837 |
Treponema pallidum | NADH oxidase | 0.0018 | 0.0044 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.1318 | 0.1356 |
Mycobacterium ulcerans | cytochrome P450 105Q4 Cyp105Q4 | 0.0048 | 0.2068 | 0.2033 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0018 | 0.0044 | 0.5 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0051 | 0.2268 | 0.2985 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0116 | 0.6629 | 0.8837 |
Plasmodium falciparum | thioredoxin reductase | 0.0051 | 0.2268 | 1 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0166 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.2068 | 0.2128 |
Mycobacterium ulcerans | cytochrome P450 187A4 Cyp187A4 | 0.0048 | 0.2068 | 0.2033 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.2453 | 0.2453 |
Mycobacterium tuberculosis | Probable cytochrome P450 128 Cyp128 | 0.0048 | 0.2068 | 0.2717 |
Plasmodium vivax | glutathione reductase, putative | 0.0051 | 0.2268 | 1 |
Schistosoma mansoni | cytochrome P450 | 0.0048 | 0.2068 | 0.2128 |
Loa Loa (eye worm) | glutathione reductase | 0.0051 | 0.2268 | 0.2268 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0018 | 0.0044 | 0.0045 |
Mycobacterium ulcerans | cytochrome P450 144A4 Cyp144A4 | 0.0048 | 0.2068 | 0.2033 |
Trypanosoma brucei | cytochrome P450, putative | 0.0166 | 1 | 1 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0048 | 0.2068 | 0.2033 |
Brugia malayi | cytochrome P450 | 0.0048 | 0.2068 | 0.2068 |
Mycobacterium ulcerans | cytochrome P450 136A2 Cyp136A2 | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium tuberculosis | Probable cytochrome P450 123 Cyp123 | 0.0048 | 0.2068 | 0.2717 |
Leishmania major | cytochrome p450-like protein | 0.0166 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0166 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0166 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 monooxygenase 142 Cyp142 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0116 | 0.6629 | 0.8403 |
Brugia malayi | Cytochrome P450 family protein | 0.0048 | 0.2068 | 0.2068 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0018 | 0.0044 | 0.0194 |
Mycobacterium ulcerans | cytochrome P450 51B1 Cyp51B1 | 0.0048 | 0.2068 | 0.2033 |
Mycobacterium ulcerans | cytochrome P450 125A7 Cyp125A7 | 0.0048 | 0.2068 | 0.2033 |
Plasmodium falciparum | glutathione reductase | 0.0051 | 0.2268 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 124 Cyp124 | 0.0048 | 0.2068 | 0.2717 |
Mycobacterium ulcerans | cytochrome P450 150A6 Cyp150A6 | 0.0048 | 0.2068 | 0.2033 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0018 | 0.0044 | 0.5 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0048 | 0.2068 | 0.9101 |
Brugia malayi | Cytochrome P450 family protein | 0.0166 | 1 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0116 | 0.6629 | 0.8837 |
Mycobacterium ulcerans | cytochrome p450 150 cyp150 | 0.0048 | 0.2068 | 0.2033 |
Leishmania major | trypanothione reductase | 0.0051 | 0.2268 | 0.2234 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0018 | 0.0044 | 0.5 |
Trypanosoma cruzi | cytochrome p450-like protein, putative | 0.0048 | 0.2068 | 0.2033 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.